WEDNESDAY, Dec. 10, 2025 (HealthDay News) — Artificial intelligence (AI) can help improve treatment of epilepsy by connecting ...

AI-powered registries may improve epilepsy care by extracting data from incomplete medical records, easing the burden on clinicians when decisions are necessary regarding surgical evaluations, data ...

Emerging clinical and autopsy evidence points to late-onset epilepsy as a potentially distinct, neurodegeneration-related ...

Research last month suggested that starting GLP-1 receptor agonist treatment in people with epilepsy and type 2 diabetes was ...

A pilot deployment of a generative artificial intelligence (AI) registry identified patients with drug-resistant epilepsy ...

A recent study points to a potential link between GLP-1 drugs and its ability to reduce risk of epilepsy in people with type 2 diabetes. GLP-1 drugs (semaglutide) are those which mimic the function of ...

Attained seizure freedom: Among the participants treated for ≥48 months in the OLE (n=131), seizure freedom for any ≥12-, ≥24-, ≥36-, and ≥48-month consecutive durations was attained by 38.2%, 25.2%, ...

Fake clickbait TikTok videos about epilepsy treatments are receiving more views than accurate, evidence-based offerings, a ...

Dr. Samuel Terman from the University of Michigan, who led the second study, said that people with both epilepsy and ...

SAN FRANCISCO and ATLANTA, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Citizen Health today announced a new strategic partnership with UCB, a global biopharmaceutical leader in neurological and autoimmune ...